Published in PLoS One on September 08, 2011
Sialic Acid on the Glycosylphosphatidylinositol Anchor Regulates PrP-mediated Cell Signaling and Prion Formation. J Biol Chem (2015) 0.88
The ZIP5 ectodomain co-localizes with PrP and may acquire a PrP-like fold that assembles into a dimer. PLoS One (2013) 0.84
Conserved roles of the prion protein domains on subcellular localization and cell-cell adhesion. PLoS One (2013) 0.81
Proteomic identification of mammalian cell surface derived glycosylphosphatidylinositol-anchored proteins through selective glycan enrichment. Proteomics (2014) 0.78
Secretory pathway retention of mutant prion protein induces p38-MAPK activation and lethal disease in mice. Sci Rep (2016) 0.78
PrPC Undergoes Basal to Apical Transcytosis in Polarized Epithelial MDCK Cells. PLoS One (2016) 0.75
Sialic Acid within the Glycosylphosphatidylinositol Anchor Targets the Cellular Prion Protein to Synapses. J Biol Chem (2016) 0.75
Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature (1992) 9.01
Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J Cell Biol (1986) 8.74
Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol (1987) 7.05
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature (2009) 6.99
Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science (2005) 5.52
The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. J Biol Chem (1991) 4.23
Mechanism of membrane anchoring affects polarized expression of two proteins in MDCK cells. Science (1989) 3.59
Structural clues to prion replication. Science (1994) 3.43
N-glycans as apical sorting signals in epithelial cells. Nature (1995) 2.68
Physiology of the prion protein. Physiol Rev (2008) 2.65
The glycosylphosphatidylinositol anchor: a complex membrane-anchoring structure for proteins. Biochemistry (2008) 2.40
Functionally different GPI proteins are organized in different domains on the neuronal surface. EMBO J (1999) 2.35
Axonal prion protein is required for peripheral myelin maintenance. Nat Neurosci (2010) 2.25
AP1B sorts basolateral proteins in recycling and biosynthetic routes of MDCK cells. Proc Natl Acad Sci U S A (2007) 1.92
N-Glycans mediate the apical sorting of a GPI-anchored, raft-associated protein in Madin-Darby canine kidney cells. J Cell Biol (1999) 1.86
Preferred apical distribution of glycosyl-phosphatidylinositol (GPI) anchored proteins: a highly conserved feature of the polarized epithelial cell phenotype. J Membr Biol (1990) 1.76
The membrane domains occupied by glycosylphosphatidylinositol-anchored prion protein and Thy-1 differ in lipid composition. J Biol Chem (2003) 1.73
Sympathetic innervation of lymphoreticular organs is rate limiting for prion neuroinvasion. Neuron (2001) 1.64
Protein oligomerization modulates raft partitioning and apical sorting of GPI-anchored proteins. J Cell Biol (2004) 1.59
Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring. PLoS Pathog (2010) 1.49
Apical sorting by galectin-3-dependent glycoprotein clustering. Traffic (2007) 1.45
Host PrP glycosylation: a major factor determining the outcome of prion infection. PLoS Biol (2008) 1.44
Blockade of glycosylation promotes acquisition of scrapie-like properties by the prion protein in cultured cells. J Biol Chem (1997) 1.40
Site-specific characterization of the N-linked glycans of murine prion protein by high-performance liquid chromatography/electrospray mass spectrometry and exoglycosidase digestions. Biochemistry (1999) 1.40
Regional heterogeneity of cellular prion protein isoforms in the mouse brain. Brain (2003) 1.37
GPI-anchored proteins are directly targeted to the apical surface in fully polarized MDCK cells. J Cell Biol (2006) 1.36
PrPc glycoform heterogeneity as a function of brain region: implications for selective targeting of neurons by prion strains. J Neuropathol Exp Neurol (1999) 1.31
Heterogeneity of normal prion protein in two- dimensional immunoblot: presence of various glycosylated and truncated forms. J Neurochem (2002) 1.18
Galectin-9 trafficking regulates apical-basal polarity in Madin-Darby canine kidney epithelial cells. Proc Natl Acad Sci U S A (2010) 1.14
Olfactory behavior and physiology are disrupted in prion protein knockout mice. Nat Neurosci (2008) 1.11
Oligomerization is a specific requirement for apical sorting of glycosyl-phosphatidylinositol-anchored proteins but not for non-raft-associated apical proteins. Traffic (2007) 1.07
Loss of glycosylation associated with the T183A mutation in human prion disease. Acta Neuropathol (2004) 1.06
Recombinant addition of N-glycosylation sites to the basolateral Na,K-ATPase beta1 subunit results in its clustering in caveolae and apical sorting in HGT-1 cells. J Biol Chem (2005) 1.04
Expression of unglycosylated mutated prion protein facilitates PrP(Sc) formation in neuroblastoma cells infected with different prion strains. J Gen Virol (2000) 1.04
Intracellular accumulation of the cellular prion protein after mutagenesis of its Asn-linked glycosylation sites. Glycobiology (1990) 1.02
Different GPI-attachment signals affect the oligomerisation of GPI-anchored proteins and their apical sorting. J Cell Sci (2008) 1.02
PrPc does not mediate internalization of PrPSc but is required at an early stage for de novo prion infection of Rov cells. J Virol (2007) 1.01
PrPC is sorted to the basolateral membrane of epithelial cells independently of its association with rafts. Traffic (2002) 0.98
Analysis of membrane traffic in polarized epithelial cells. Curr Protoc Cell Biol (2001) 0.95
Altered glycosylated PrP proteins can have different neuronal trafficking in brain but do not acquire scrapie-like properties. J Biol Chem (2005) 0.95
N-glycans, not the GPI anchor, mediate the apical targeting of a naturally glycosylated, GPI-anchored protein in polarised epithelial cells. J Cell Sci (2004) 0.94
Molecular dynamics simulation of human prion protein including both N-linked oligosaccharides and the GPI anchor. Glycobiology (2000) 0.93
Heterogeneity and regulation of cellular prion protein glycoforms in neuronal cell lines. Eur J Neurosci (2003) 0.93
Lack of a-disintegrin-and-metalloproteinase ADAM10 leads to intracellular accumulation and loss of shedding of the cellular prion protein in vivo. Mol Neurodegener (2011) 0.92
Glycosylation and prion protein. Curr Opin Struct Biol (2002) 0.92
The surface glycoprotein Thy-1 is excluded from growing axons during development: a study of the expression of Thy-1 during axogenesis in hippocampus and hindbrain. Development (1991) 0.90
Changes in the glycosylation pattern of prion protein in murine scrapie. Implications for the mechanism of neurodegeneration in prion diseases. J Biol Chem (2002) 0.89
T-cadherin GPI-anchor is insufficient for apical targeting in MDCK cells. Biochem Biophys Res Commun (2005) 0.88
Residues surrounding the glycosylphosphatidylinositol anchor attachment site of PrP modulate prion infection: insight from the resistance of rabbits to prion disease. J Virol (2010) 0.88
Prion propagation in cells expressing PrP glycosylation mutants. J Virol (2011) 0.88
A pathogenic PrP mutation and doppel interfere with polarized sorting of the prion protein. J Biol Chem (2004) 0.87
Serine phosphorylation site of the 46-kDa mannose 6-phosphate receptor is required for transport to the plasma membrane in Madin-Darby canine kidney and mouse fibroblast cells. Mol Biol Cell (1997) 0.86
Understanding the natural variability of prion diseases. Vaccine (2007) 0.86
Characterization of the F198S prion protein mutation: enhanced glycosylation and defective refolding. J Alzheimers Dis (2005) 0.84
Thr but Asn of the N-glycosylation sites of PrP is indispensable for its misfolding. Biochem Biophys Res Commun (2008) 0.82
Dropping anchor with the lipophosphoglycans. Curr Biol (1991) 0.81
Human cellular prion protein hPrPC is sorted to the apical membrane of epithelial cells. Biochem Biophys Res Commun (2007) 0.80
Foreword: lipid rafts/biophysics, cell signalling, trafficking and processing. Mol Membr Biol (2006) 0.76
Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease. Lancet Neurol (2005) 2.91
Genetic prion disease: the EUROCJD experience. Hum Genet (2005) 2.64
The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak. Brain (2012) 2.49
Neuronal ceroid lipofuscinoses. Biochim Biophys Acta (2008) 2.29
A key enzyme in the biogenesis of lysosomes is a protease that regulates cholesterol metabolism. Science (2011) 1.98
Mucolipidosis II is caused by mutations in GNPTA encoding the alpha/beta GlcNAc-1-phosphotransferase. Nat Med (2005) 1.93
The disintegrin/metalloproteinase ADAM10 is essential for the establishment of the brain cortex. J Neurosci (2010) 1.85
Shaken baby syndrome: a common variant of non-accidental head injury in infants. Dtsch Arztebl Int (2009) 1.83
Autoantibodies against beta-amyloid are common in Alzheimer's disease and help control plaque burden. Ann Neurol (2009) 1.65
Prion infections, blood and transfusions. Nat Clin Pract Neurol (2006) 1.64
Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion. Nature (2003) 1.51
Target-dependent specification of the neurotransmitter phenotype: cholinergic differentiation of sympathetic neurons is mediated in vivo by gp 130 signaling. Development (2005) 1.44
Analysis of prion strains by PrPSc profiling in sporadic Creutzfeldt-Jakob disease. PLoS Med (2005) 1.43
CLP1 links tRNA metabolism to progressive motor-neuron loss. Nature (2013) 1.41
Strain fidelity of chronic wasting disease upon murine adaptation. J Virol (2006) 1.40
Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke. Blood (2012) 1.39
Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease. Acta Neuropathol (2013) 1.34
Scoring evaluation of the natural course of mucopolysaccharidosis type IIIA (Sanfilippo syndrome type A). Pediatrics (2007) 1.31
Protein kinase a dependent phosphorylation of apical membrane antigen 1 plays an important role in erythrocyte invasion by the malaria parasite. PLoS Pathog (2010) 1.29
Mannose phosphorylation in health and disease. Eur J Cell Biol (2009) 1.24
Oral prion infection requires normal numbers of Peyer's patches but not of enteric lymphocytes. Am J Pathol (2003) 1.21
Relevance of PTEN loss in brain metastasis formation in breast cancer patients. Breast Cancer Res (2012) 1.20
Genomic profiles associated with early micrometastasis in lung cancer: relevance of 4q deletion. Clin Cancer Res (2009) 1.19
Chronic wasting disease prions are not transmissible to transgenic mice overexpressing human prion protein. J Gen Virol (2010) 1.19
A new type of congenital disorders of glycosylation (CDG-Ii) provides new insights into the early steps of dolichol-linked oligosaccharide biosynthesis. J Biol Chem (2003) 1.15
Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions. Immunity (2009) 1.10
Functional biology of the neuronal ceroid lipofuscinoses (NCL) proteins. Biochim Biophys Acta (2006) 1.09
Cell biology and function of neuronal ceroid lipofuscinosis-related proteins. Biochim Biophys Acta (2013) 1.09
Ocular pathology in shaken baby syndrome and other forms of infantile non-accidental head injury. Int J Legal Med (2008) 1.07
Unhampered prion neuroinvasion despite impaired fast axonal transport in transgenic mice overexpressing four-repeat tau. J Neurosci (2002) 1.04
Intrinsic resistance of oligodendrocytes to prion infection. J Neurosci (2004) 1.04
Defective endoplasmic reticulum-resident membrane protein CLN6 affects lysosomal degradation of endocytosed arylsulfatase A. J Biol Chem (2004) 1.04
Analysis of potential biomarkers and modifier genes affecting the clinical course of CLN3 disease. Mol Med (2011) 1.04
Molecular order in mucolipidosis II and III nomenclature. Am J Med Genet A (2008) 1.03
STAT3 silencing inhibits glioma single cell infiltration and tumor growth. Neuro Oncol (2013) 1.02
Dietary curcumin attenuates glioma growth in a syngeneic mouse model by inhibition of the JAK1,2/STAT3 signaling pathway. Clin Cancer Res (2010) 1.02
Missense mutation in the N-acetylglucosamine-1-phosphotransferase gene (GNPTA) in a patient with mucolipidosis II induces changes in the size and cellular distribution of GNPTG. Hum Mutat (2006) 1.01
Efficient chemotherapy of rat glioblastoma using doxorubicin-loaded PLGA nanoparticles with different stabilizers. PLoS One (2011) 0.99
C-terminal prenylation of the CLN3 membrane glycoprotein is required for efficient endosomal sorting to lysosomes. Traffic (2007) 0.99
Immune system and peripheral nerves in propagation of prions to CNS. Br Med Bull (2003) 0.98
Glycosylation- and phosphorylation-dependent intracellular transport of lysosomal hydrolases. Biol Chem (2009) 0.97
Postnatal disruption of the disintegrin/metalloproteinase ADAM10 in brain causes epileptic seizures, learning deficits, altered spine morphology, and defective synaptic functions. J Neurosci (2013) 0.97
Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice. Brain (2009) 0.97
Opposite roles of FOXA1 and NKX2-1 in lung cancer progression. Genes Chromosomes Cancer (2012) 0.96
Hypoxia and oxygenation induce a metabolic switch between pentose phosphate pathway and glycolysis in glioma stem-like cells. Acta Neuropathol (2013) 0.96
Decreased bone formation and increased osteoclastogenesis cause bone loss in mucolipidosis II. EMBO Mol Med (2013) 0.96
Phenotypic profile of early-onset familial Alzheimer's disease caused by presenilin-1 E280A mutation. J Alzheimers Dis (2012) 0.95
Missense mutations in N-acetylglucosamine-1-phosphotransferase alpha/beta subunit gene in a patient with mucolipidosis III and a mild clinical phenotype. Am J Med Genet A (2005) 0.95
Mass spectrometric analysis of neutral and anionic N-glycans from a Dictyostelium discoideum model for human congenital disorder of glycosylation CDG IL. J Proteome Res (2013) 0.94
A dileucine motif and a cluster of acidic amino acids in the second cytoplasmic domain of the batten disease-related CLN3 protein are required for efficient lysosomal targeting. J Biol Chem (2004) 0.94
Creutzfeldt-Jakob disease and inclusion body myositis: abundant disease-associated prion protein in muscle. Ann Neurol (2004) 0.94
High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease. Brain (2014) 0.94
Retention of lysosomal protein CLN5 in the endoplasmic reticulum causes neuronal ceroid lipofuscinosis in Asian sibship. Hum Mutat (2009) 0.93
Deposition of hyperphosphorylated tau in cerebellum of PS1 E280A Alzheimer's disease. Brain Pathol (2011) 0.92
Cerebrovascular P-glycoprotein expression is decreased in Creutzfeldt-Jakob disease. Acta Neuropathol (2006) 0.92
Lack of a-disintegrin-and-metalloproteinase ADAM10 leads to intracellular accumulation and loss of shedding of the cellular prion protein in vivo. Mol Neurodegener (2011) 0.92
Glutaric aciduria type 1 metabolites impair the succinate transport from astrocytic to neuronal cells. J Biol Chem (2011) 0.92
ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis. EMBO Mol Med (2013) 0.92
Association between deposition of beta-amyloid and pathological prion protein in sporadic Creutzfeldt-Jakob disease. Neurodegener Dis (2008) 0.92
Induced prion protein controls immune-activated retroviruses in the mouse spleen. PLoS One (2007) 0.91
Preclinical deposition of pathological prion protein in muscle of experimentally infected primates. PLoS One (2010) 0.91
Lysoplex: An efficient toolkit to detect DNA sequence variations in the autophagy-lysosomal pathway. Autophagy (2015) 0.91
Disruption of the autophagy-lysosome pathway is involved in neuropathology of the nclf mouse model of neuronal ceroid lipofuscinosis. PLoS One (2012) 0.91
Mucolipidosis II-related mutations inhibit the exit from the endoplasmic reticulum and proteolytic cleavage of GlcNAc-1-phosphotransferase precursor protein (GNPTAB). Hum Mutat (2014) 0.91
Disease-causing missense mutations affect enzymatic activity, stability and oligomerization of glutaryl-CoA dehydrogenase (GCDH). Hum Mol Genet (2008) 0.91
A novel single-chain antibody fragment for detection of mannose 6-phosphate-containing proteins: application in mucolipidosis type II patients and mice. Am J Pathol (2010) 0.90
Podoplanin and CD34 in peripheral nerve sheath tumours: focus on neurofibromatosis 1-associated atypical neurofibroma. J Neurooncol (2010) 0.89
Compensatory expression of human N-acetylglucosaminyl-1-phosphotransferase subunits in mucolipidosis type III gamma. Biochim Biophys Acta (2009) 0.89
Loss of CADM1 expression is associated with poor prognosis and brain metastasis in breast cancer patients. Oncotarget (2014) 0.89
A replacement of the active-site aspartic acid residue 293 in mouse cathepsin D affects its intracellular stability, processing and transport in HEK-293 cells. Biochem J (2003) 0.89
Nonaccidental head injury is the most common cause of subdural bleeding in infants <1 year of age. Pediatrics (2009) 0.89
Pathogenic mutations cause rapid degradation of lysosomal storage disease-related membrane protein CLN6. Hum Mutat (2010) 0.88
Frequent genetic alterations in EGFR- and HER2-driven pathways in breast cancer brain metastases. Am J Pathol (2013) 0.88
Proteolytic processing of the prion protein in health and disease. Am J Neurodegener Dis (2012) 0.88
The GPI-anchoring of PrP: implications in sorting and pathogenesis. Prion (2014) 0.88
Familial Alzheimer's disease-associated presenilin-1 alters cerebellar activity and calcium homeostasis. J Clin Invest (2014) 0.88
Sporadic Creutzfeldt-Jakob disease: a comparison of pathological findings and diffusion weighted imaging. J Neurol (2005) 0.88
Accumulation of bis(monoacylglycero)phosphate and gangliosides in mouse models of neuronal ceroid lipofuscinosis. J Neurochem (2008) 0.87
Increased expression of lysosomal acid phosphatase in CLN3-defective cells and mouse brain tissue. J Neurochem (2007) 0.87
Transport of the GlcNAc-1-phosphotransferase α/β-subunit precursor protein to the Golgi apparatus requires a combinatorial sorting motif. J Biol Chem (2012) 0.87
Topology and endoplasmic reticulum retention signals of the lysosomal storage disease-related membrane protein CLN6. Mol Membr Biol (2007) 0.87
A novel mutation in UDP-N-acetylglucosamine-1-phosphotransferase gamma subunit (GNPTAG) in two siblings with mucolipidosis type III alters a used glycosylation site. Hum Mutat (2004) 0.87
Acute renal proximal tubule alterations during induced metabolic crises in a mouse model of glutaric aciduria type 1. Biochim Biophys Acta (2013) 0.86
Loss of N-acetylglucosamine-1-phosphotransferase gamma subunit due to intronic mutation in GNPTG causes mucolipidosis type III gamma: Implications for molecular and cellular diagnostics. Am J Med Genet A (2010) 0.86
BM88/CEND1 coordinates cell cycle exit and differentiation of neuronal precursors. Proc Natl Acad Sci U S A (2007) 0.86
Understanding the natural variability of prion diseases. Vaccine (2007) 0.86
Mannose 6 dephosphorylation of lysosomal proteins mediated by acid phosphatases Acp2 and Acp5. Mol Cell Biol (2011) 0.86
The mutation p.Ser298Pro in the sulphamidase gene (SGSH) is associated with a slowly progressive clinical phenotype in mucopolysaccharidosis type IIIA (Sanfilippo A syndrome). Hum Mutat (2008) 0.86
Proteolytic processing of the gamma-subunit is associated with the failure to form GlcNAc-1-phosphotransferase complexes and mannose 6-phosphate residues on lysosomal enzymes in human macrophages. J Biol Chem (2010) 0.86
Transport and distribution of 3-hydroxyglutaric acid before and during induced encephalopathic crises in a mouse model of glutaric aciduria type 1. Biochim Biophys Acta (2008) 0.86
Organic anion transporters OAT1 and OAT4 mediate the high affinity transport of glutarate derivatives accumulating in patients with glutaric acidurias. Pflugers Arch (2008) 0.85
Endothelial effects of 3-hydroxyglutaric acid: implications for glutaric aciduria type I. Pediatr Res (2006) 0.85
Scrapie infection of prion protein-deficient cell line upon ectopic expression of mutant prion proteins. J Biol Chem (2007) 0.85
Treatment of glioblastoma with poly(isohexyl cyanoacrylate) nanoparticles. Int J Pharm (2011) 0.84